Counterforce Health Team

Counterforce Health Team

Get Oxervate (Cenegermin) Covered by Cigna in New York: Prior Authorization Guide, Appeals Process & Alternative Treatments

Answer Box: Getting Oxervate (Cenegermin) Covered by Cigna in New York Oxervate (cenegermin) requires prior authorization from Cigna and typically involves step therapy with alternatives like preservative-free artificial tears and autologous serum drops first. If denied, you have 180 days for internal appeals and can request external review through New
6 min read

How to Get Nourianz (Istradefylline) Covered by Cigna in Washington: Appeals, Forms & Timeline Guide

Answer Box: Getting Nourianz (Istradefylline) Covered by Cigna in Washington Nourianz (istradefylline) requires prior authorization from Cigna and often faces step therapy requirements. Most denials stem from missing documentation of failed trials with amantadine, MAO-B inhibitors (rasagiline, safinamide), and COMT inhibitors (entacapone, opicapone). First step today: Contact your neurologist to
6 min read

Renewing Joenja (Leniolisib) Coverage with Aetna CVS Health in Texas: 2025 Requirements and Timeline

Answer Box: Renewing Joenja (Leniolisib) with Aetna CVS Health in Texas Aetna CVS Health requires annual prior authorization renewal for Joenja (leniolisib) in Texas, typically 30 days before your current approval expires. You'll need updated clinical documentation showing continued APDS diagnosis, treatment response (reduced lymphadenopathy, improved immunoglobulin levels)
5 min read

Renewing Exondys 51 (Eteplirsen) Approval with UnitedHealthcare in North Carolina: 2025 Requirements & Timeline

Answer Box: Renewing Your Exondys 51 Coverage Quick Answer: UnitedHealthcare requires annual renewal of Exondys 51 (eteplirsen) prior authorization with updated clinical documentation. Start the renewal process 60-90 days before your current authorization expires. You'll need: neurologist evaluation showing continued benefit, updated cardiac/renal function tests, and proof
6 min read

Coding That Helps Get Oxervate (cenegermin) Approved by UnitedHealthcare in California: ICD-10, HCPCS, and NDC Guide

Answer Box: Getting Oxervate Covered by UnitedHealthcare in California Oxervate (cenegermin) requires prior authorization from UnitedHealthcare with specific coding requirements. Use ICD-10 codes H16.231-H16.233 for stage 2/3 neurotrophic keratitis, HCPCS code J3590, and NDC 71923-019-01. Submit through OptumRx with documented artificial tear failure and ophthalmologist prescription. If
6 min read